tbuckley/cabot-search huggingface dataset:
Factors Affecting Early Immune Recovery after Autologous Transplantation and Its Clinical Significance - a Prospective Analysis of Patients with Non-Hodgkin Lymphoma
Authors: Jaakko Valtola, Ville Varmavuo, Antti Ropponen, Tuomas Selander, Hanne Kuitunen, Leena Keskinen, Kaija Vasala, Tapio Nousiainen, Pentti Mäntymaa, Jukka Pelkonen, Esa Jantunen
Journal: Blood (2015)
Dynamics and Prognostic Impact of Peripheral Blood Blast Clearance in Patients with Acute Myeloid Leukemia (AML) Receiving FLT3 Inhibitor Therapy in Combination with Induction Chemotherapy
Authors: Christopher B. Benton, Peng Qiu, Farhad Ravandi, Hagop M. Kantarjian, Guillermo Garcia-Manero, Sherry A. Pierce, Anisha Borthakur, Marina Konopleva, Jorge E. Cortes, Michael Andreeff, Alfonso Quintás-Cardama
Journal: Blood (2012)
OC-028 Does Duodenal Histology Yield any Other Diagnoses for Iron Deficiency Anaemia Apart From Coeliac Disease?: Abstract OC-028 Table 1
Authors: MS Lau, PD Mooney, WL White, M Burden, SH Wong, M Kurien, SS Cross, JM Hebden, DS Sanders
Journal: Gut (2016)

<h3>Introduction</h3> The prevalence of iron deficiency anaemia (IDA) is 2–5% in the developed world. The BSG IDA guidelines recommend screening for coeliac disease (CD) with serology, and those tested positive should undergo duodenal biopsy to assess for villous atrophy (VA). The availability of pre-endoscopy serology in IDA has been shown to be 30%, thus often committing clinicians to routinely biopsy the duodenum. We aimed to explore whether any causes other than CD would be found on duodenal biopsy in IDA. We also aimed to evaluate the role of Simtomax, an IgA/G-deamidated gliadin peptide based point of care test (POCT), in detecting CD in IDA in the endoscopy setting. <h3>Methods</h3> Group 1: we retrospectively reviewed the duodenal histology of 153 patients with IDA attending a non coeliac specialised IDA clinic in 2013–14. Group 2: we prospectively recruited 133 patients with iron deficiency attending for a gastroscopy to our research gastroscopy list. All patients undertook Simtomax, endomysial antibodies (EMA), tissue transglutaminase (TTG), total IgA, and 5 duodenal biopsies. The results were compared against histology. <h3>Results</h3> The duodenal histology in group 1 yielded no cause for the IDA apart from CD. Two patients had VA- 1 with positive serology and hence was diagnosed with CD; the other patient never had a serology to confirm the diagnosis as he subsequently died from colon cancer. Assuming the latter case to be CD, the prevalence of CD in this cohort would be 1.3%. 5/7 patients with lymphocytic duodenosis (LD) had a cause for or association with LD: vitiligo, autoimmune hypothyroidism, aspirin use, proton pump inhibitor use, and Helicobacter pylori infection respectively. No attributable causes for LD were found in the remaining 2 patients. In group 2, the prevalence of CD was 19.5%. The sensitivity and NPV of Simtomax were 100%. <h3>Conclusion</h3> Our duodenal histology review revealed no alternative causes for the IDA other than villous atrophy secondary to CD. Simtomax had 100% sensitivity and NPV for detecting CD in IDA. This suggests that performing a duodenal biopsy in patients with a negative Simtomax test is highly unlikely to yield a diagnosis for IDA, thus could be safely avoided if the sole purpose of the biopsy is to investigate IDA. Simtomax could provide significant cost savings by targeting patients with IDA who require a duodenal biopsy. <h3>Disclosure of Interest</h3> M. Lau: None Declared, P. Mooney: None Declared, W. White: None Declared, M. Burden: None Declared, S. Wong: None Declared, M. Kurien: None Declared, S. Cross: None Declared, J. Hebden: None Declared, D. Sanders Grant/research support from: Tillotts Pharma for investigator led studies in coeliac disease. None of the funding sources had any input in the study design, access to study data, interpretation of the findings or drafting of the abstract.
Cytomegalovirus (CMV)-Specific CD8+ T Cells Are Associated with Control of Viral Reactivation Post-Hemopoietic Stem Cell Transplantation (HSCT) Only If Shown to Be Functionally Active.
Authors: Stephanie Verfuerth, Karl S Peggs, Arnold Pizzey, Noha Chowdhry, Stephen Mackinnon
Journal: Blood (2008)
BMA gives up strike mandate on junior contract
Authors: Abi Rimmer
Journal: BMJ (2016)

The BMA has decided to give up its ability to take industrial action over changes to the junior doctor contract in England.

In an email to members sent on 10 November, Peter Campbell, interim chair of the BMA’s Junior Doctors Committee (JDC), said that it had decided to end its current mandate for industrial action. The decision means that there would need to be a fresh ballot before any future industrial action could take place.

The phased implementation of the new junior doctors’ contract began in October, with trainees …
PTH-113 Health-Related Quality of Life, Psychological Well-Being and Socioeconomic Impact in Patients with Cirrhosis and Their Caregivers
Authors: S Vadera, L Greenslade, MY Morgan
Journal: Gut (2016)

<h3>Introduction</h3> The psychological, social and economic consequences of a diagnosis of cirrhosis, for both patients and their families/friends, are not routinely assessed in the UK. The aim of this study was to assess Health-related Quality of Life (HRQoL), psychological well-being and socioeconomic burden in a random sample of patients with cirrhosis and their caregivers. <h3>Methods</h3> The patient population comprised 51 patients with cirrhosis (38 men: 13 women; mean age 55 [21–87] yr) with no evidence of fluid retention utilising hospital inpatient/outpatient facilities and 15 patients (nine men: six women; mean age 60 [36–82] yr) attending the day-ward for large volume paracentesis (LVP). HRQoL was assessed using the generic <i>EQ-5D</i> questionnaire. The frequency of anxiety and depression was assessed using the <i>Beck Anxiety </i>(<i>BAI</i>) and <i>Depression</i> (<i>BDI</i>) inventories. The impact on employment and disease–related costs were assessed using an adapted financial questionnaire.<sup>1</sup> Caregivers’ burden was assessed in 20 relatives/friends using the <i>Perceived Caregivers Burden Scale</i> and the <i>Zarit Burden Interview</i>. All patients/caregivers were interviewed to obtain additional information on psychosocial and general well-being. A control population of 52 individuals (28 men: 24 women; mean age 49 [26–68] yr) was also included. <h3>Results</h3> HRQoL was significantly impacted in both the general patients with cirrhosis and in those undergoing LVP, compared to controls (<i>EQ-5D:</i> 0.51±0.32 and 0.52±0.18 <i>vs</i><i>.</i> 0.92±0.11; p &lt; 0.001). The frequency of anxiety and depression was also significantly increased in the general patients with cirrhosis (<i>BAI</i> 18.9±15.9: <i>BDI</i> 17.6±12.7; p &lt; 0.001) and those undergoing LVP (<i>BAI</i> 17.1±11.0: <i>BDI</i> 15.6±7.4; p &lt; 0.001), compared with controls (<i>BAI</i> 4.3±4.7: <i>BDI</i> 4.5±4.5; p &lt; 0.001). Two-thirds of the general patients with cirrhosis and 100% of those undergoing LVP were unemployed; 50% considered their diagnosis had impacted on their employment status. The majority of patients were financially impacted, with direct out-of-pocket expenses, e.g. for hospital transport costs, of £350-£1500 since diagnosis. Approximately 15% of caregivers reported moderate anxiety while 5% reported moderate depression. The majority of caregivers were assessed as having a moderate degree of burden. <h3>Conclusion</h3> Patients with cirrhosis have poor HRQoL and are often depressed and anxious; in addition they frequently have undisclosed socioeconomic difficulties. Caregivers are also detrimentally affected. Attention needs to be paid to the holistic needs of patients and careers, particularly in relation to their psychosocial and financial well-being. <h3>Reference</h3> 1 Bajaj JS, <i>et al. Am J Gastroenterol</i> 2011;<b>106</b>:1646–53. <h3>Disclosure of Interest</h3> None Declared
AB0458 Serum Ferritin as A Biomarker of Clinical and Histopathological Response To Treatment in Lupus Nephritis
Authors: I. Parodis, H. Ding, A. Zickert, L. Arnaud, C. Mohan, I. Gunnarsson
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Lupus nephritis (LN) is a major organ manifestation of Systemic Lupus Erythematosus (SLE). Renal biopsy is the current gold standard for assessment of renal pathology in LN, as non-invasive reliable markers are lacking. Ferritin is found in most tissues as a cytosolic protein that stores iron. Small amounts are secreted into the serum, where ferritin functions as an iron carrier. Ferritin is considered an acute phase protein, as it increases in response to stresses. Studies have reported elevated serum concentrations in patients with active compared to patients with inactive SLE, and also associations with LN. <h3>Objectives</h3> We assessed serum ferritin levels in patients with LN, in order to clarify its role in this SLE subset. <h3>Methods</h3> Serum levels of ferritin were determined by ELISA (Raybiotech Inc.) in 64 patients with biopsy-proven active LN (52 proliferative LN, PLN; 12 membranous LN, MLN), before and after completion of induction treatment. Post-treatment renal biopsies were performed after a median time of 7.7 months. Clinical responders (CR) were defined by ≥50% reduced proteinuria, normal or ≥25% improved estimated glomerular filtration rate, and inactive urinary sediment. Histopathological responders (HR) were defined by ≥50% improvement of renal Activity Index in post-treatment biopsies. <h3>Results</h3> Serum levels of ferritin decreased following induction therapy for LN in the entire cohort (p&lt;0.001) and in patients with PLN (p&lt;0.001), but not in patients with MLN (p=0.35). In the entire cohort, ferritin levels decreased in both CR (p&lt;0.001) and clinical non-responders (CNR; p=0.030). They also decreased in HR (p&lt;0.001), but remained stable in histopathological non-responders (HNR; p=0.06). In PLN, ferritin levels decreased in CR (p&lt;0.001) and in CNR (p=0.003), as well as in HR (p&lt;0.001) and HNR (p=0.011). In MLN, ferritin levels decreased in CR (p=0.03) and HR (p=0.046), but neither in CNR (p=0.69) nor in HNR (p=0.89). In patients with MLN, both baseline and post-treatment ferritin levels were higher in CNR (baseline median: 172.9 ng/mL, range: 15.9–486.3; post-treatment median: 309.7 ng/mL, range: 8.4–714.8) than in CR (baseline median: 59.8 ng/mL, range: 24.4–200.9; post-treatment median: 32.3 ng/mL, range: 4.9–43.2; p=0.03 and p=0.005, respectively); however, they did not differ between HR and HNR (p=0.79 and p=0.43, respectively). <h3>Conclusions</h3> Our data suggest ferritin as a marker of histopathological response to induction treatment in patients with LN. In patients with MLN in particular, high baseline ferritin levels predicted unfavourable clinical response to induction treatment, and, despite being initially lower, baseline ferritin levels decreased in CR. This implies a role of ferritin in the pathogenesis of this LN subset and warrants further investigation. <h3>Disclosure of Interest</h3> None declared
Dendritic Cells Co-Developing from Human CD34+ Cells Following Incubation with Thrombopoietin and Tumor Necrosis Factor-α Phagocytose Self-Megakaryocytic Progenitors and Induce Autologous T-Cell Proliferation.
Authors: Kunie Saito, Makoto Hirokawa, Hiroshi Fukaya, Yoshinari Kawabata, AtAtsushi Komatsuda, JuJunsuke Yamashita, Ken-Ichi Sawada
Journal: Blood (2004)
Prostaglandin E2 Promotes the Sequential Recovery of Bone Marrow Vasculature and the Megakaryocyte Lineage Following Radiation Injury
Authors: Lisa M. Niswander, Anne D. Koniski, Andrew Seraichick, Seana C. Catherman, Katherine H. Fegan, Paul D. Kingsley, Laura M. Calvi, James Palis
Journal: Blood (2015)
Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
Authors: Romeo Papazyan, Zheng Sun, Yong Hoon Kim, Paul M. Titchenell, David A. Hill, Wenyun Lu, Manashree Damle, Min Wan, Yuxiang Zhang, Erika R. Briggs, Joshua D. Rabinowitz, Mitchell A. Lazar
Journal: Cell Metabolism (2016)
Bortezomib Induces Selective Depletion of Activated T Lymphocytes and Modifies the Cytokine’s Production Pattern.
Authors: Belen Blanco, Jose A. Perez-Simon, Luis I. Sanchez-Abarca, Xonia Carvajal-Vergara, Juan Mateos, Belen Vidriales, Natalia Lopez-Holgado, Mercedes Alberca, Eva Villaron, D. Schenkein, Consuelo Canizo, Atanasio Pandiella, Jesus F. San Miguel
Journal: Blood (2005)
Adoptive T Cell Therapy for Progressive Multifocal Leukoencephalopathy Using Sequential Ex-Vivo Stimulation with JCV Peptide Pulsed Dendritic Cells and Anti-CD3/CD28
Authors: Brett Glotzbecker, Heidi Mills, Jacalyn Rosenblatt, Evelyn Bord, Chen S Tan, Sarah Gheuens, Igor Koralnik, David Avigan
Journal: Blood (2011)
Human Myeloma Cells Express the Bone Regulating Gene Runx2/Cbfa1 and Produce Osteopontin That It Is Involved in Myeloma-Induced Angiogenesis.
Authors: Nicola Giuliani, Simona Colla, Francesca Morandi, Sabrina Bonomini, Monica Crugnola, Vittorio Rizzoli
Journal: Blood (2004)
PWE-118 Metachronous Cancers Following Segmental or Extended Colectomy in Lynch Syndrome: A Systematic Review &amp; Meta-Analysis
Authors: SS Malik, M Lythgoe, KJ Monahan
Journal: Gut (2016)

<h3>Introduction</h3> Around 5% of colorectal cancers are due to mutations within DNA mismatch repair genes, resulting in Lynch Syndrome (LS). These mutations have a high penetrance (85–90%), with early onset of colorectal cancer at an average age of 45 years. The main surgical management options are either a segmental or extensive colectomy. Currently there is no unified agreement as to which management strategy is superior due to the limited conclusive empirical evidence available. A systematic review and meta- analysis to evaluate the risk of metachronous colorectal cancer (MCC) and mortality in LS following segmental and extensive colectomy. <h3>Methods</h3> A systematic review of the Pubmed database was conducted. Studies were included/ excluded based on a pre-specified criteria. In order to assess the risk of MCC and mortality attributed to segmental or extensive colectomies, pooled odds ratios (OR) were calculated and corresponding 95% confidence intervals (CI). Publication bias was investigated using funnel plots. Statistical analysis was conducted using the R program (version 3.2.3). <h3>Results</h3> The literature search identified eighty-five studies. After further analysis nine studies were eligible for inclusion in this study. Pooled data identified 1429 patients followed up for a mean of 103.1 months with a mean age of onset of 43.3 years of age. 1135 patients underwent segmental colectomies with risk of MCC in this group of 22.0% at the end of follow-up. 294 patients had extensive colectomies with a MCC risk of 4.7% (0% in those with a panproctocolecomy). A segmental colectomy was significantly associated with an increased risk of MCC (OR = 4.47; 95% CI: 2.68–7.45; Figure 1), but no significant association with mortality was identified (OR = 1.65; 95% CI: 0.71–3.82). <h3>Conclusion</h3> In LS, segmental colectomy results in a significant increased risk of developing MCC. Despite the choice of segmental or extensive colectomies having no statistically significant impact on mortality, the choice of initial surgical management can impact a patient’s requirement for further surgery. An extensive colectomy can result in decreased need for further surgery; reduced hospital stays and reduced costs. The significant difference in the risk of MCC, following segmental or extensive colectomies should be discussed with patients when deciding appropriate management. <h3>Disclosure of Interest</h3> None Declared
The Mll PTD and Flt3 ITD Double Knock-In Mouse Develops Acute Leukemia and Recapitulates Phenotypic, Molecular and Epigenetic Characteristics of the Counterpart Human Acute Myeloid Leukemia
Authors: Nicholas Zorko, Susan P. Whitman, Kelsie Bernot, Myntee T. Ngangana, Ronald Siebenaler, Shujun Liu, Yue-Zhong Wu, Chidimma Kalu, Xiaoli Zhang, David Jarjoura, Zhiliang Xie, Kenneth K. Chan, Adrienne M. Dorrance, Benjamin H. Lee, Roger Briesewitz, Danilo Perrotti, Guido Marcucci, Michael A. Caligiuri
Journal: Blood (2010)
The Role of Wilms’ Tumor Gene (WT1) Peptide-Specific Cytotoxic-T Lymphocytes in Selection of a Paroxysmal Nocturnal Hemoglobinuria (PNH) Clone.
Authors: Kazuhiko Ikeda, Tsutomu Shichishima, Akiko Shichishima-Nakamura, Masaki Yasukawa, Hideyoshi Noji, Kazuko Akutsu, Yukio Maruyama
Journal: Blood (2005)
PTU-025 Effect of the Magnetic Endoscope Imager on Colonoscopy Performance by a Single Endoscopist
Authors: LB Materacki, J Kennedy, H Kriel, T Brooklyn
Journal: Gut (2016)

<h3>Introduction</h3> Colonoscopy is the gold standard investigation for colonic assessment. To maintain clinical excellence in colonoscopy several performance indicators are recognised.<sup>1</sup> Colonic looping is a common patient-related factor which may reduce completion rates. The magnetic endoscope imager (MEI), a device which generates a three-dimensional map of colonoscope orientation, provides feedback regarding tip location and loop formation. MEI may improve colonoscopy outcomes however findings are inconsistent. This study aimed to evaluate whether MEI use improves outcomes in colonoscopy completed by a single endoscopist. <h3>Methods</h3> This retrospective cohort study investigated the effect of MEI on procedure completion, polyp detection, medication doses (sedation, analgesia and buscopan), endoscopist and nurse discomfort scores and patient satisfaction in patients undergoing colonoscopy. Data was obtained by interrogation of electronic colonoscopy records for a single gastroenterologist between December 2009 and November 2014. The equipment used for all colonoscopies was identical in make and age, the only difference being the presence or absence of the MEI. Statistical analysis was completed using Wizard©. <h3>Results</h3> 2129 colonoscopies were completed during the study period across three endoscopy units. After exclusion of incomplete data, study groups significantly differed by age demographics. By excluding patients older than 74 y, study groups (n = 914 without MEI, n = 359 with MEI) had similar age (p = 0.06) and gender (p = 0.962) characteristics. MEI use did not significantly influence colonoscopy completion (97.2% vs 96.3%, (p = 0.412)) or polyp detection (24.8% vs 29.1%, (p = 0.132)). Colonoscopies completed without MEI were associated with higher doses of midazolam (1.618 mg ± 0.051 vs 1.379 mg ± 0.097, p &lt; 0.001), fentanyl (1.313 μg ± 0.557 vs 0.348 0μg ± 0.493, p = 0.044), pethidine (24.858 mg ± 0.986 vs 23.259 mg ± 1.784, p = 0.104) and buscopan (16.247 mg ± 0.526 vs 13.510 mg ± 1.041, p &lt; 0.001). Comfort scores and patient satisfaction outcomes were sub-analysed in colonoscopies completed without analgesia or sedation (n = 244). MEI use did not significantly affect endoscopist (p = 0.383) or nurse discomfort scores (p = 0.383 and p = 0.971) or patient satisfaction ratings (p = 0.209). <h3>Conclusion</h3> Real world use of MEI at colonoscopy did not improve polyp detection or completion rates but was associated with decreased analgesia, sedation and buscopan use. Unsedated colonoscopy was associated with similar comfort and satisfaction scores regardless of MEI use. Endoscopists may anticipate greater discomfort without MEI and overcompensate sedation doses. Medication dosing should remain consistent regardless of MEI availability. <h3>Reference</h3> 1 BSG quality and safety indicators for endoscopy. JAG advisory group on GI endoscopy. March 2007. <h3>Disclosure of Interest</h3> None Declared
Haploidentical BMT with a Post-Infusion of Stem Cells Cyclophosphamide Approach Is Feasible and Leads to a High Rate of Donor Engraftment in Haemoglobinopathies Allowing Universal Application of Transplantation
Authors: Josu de la Fuente, Farah O'Boyle, Yvonne Harrington, Anne Bradshaw, Sandra Hing, Subarna Chakravorty, Leena Karnik, Helen New, Richard Szydlo, Baba PD Inusa, Paul Telfer
Journal: Blood (2015)
Genomic Analysis of High Hyperdiploid Acute Lymphoblastic Leukemia and Hyperdiploid Multiple Myeloma Suggests Differential Gene Dosage Effect on Expression and Provide Clues to Preferential Selection of Recurrently Trisomic Chromosomes.
Authors: Wee-Joo Chng, Scott Van Wier, Gregory Ahmann, Tammy Price-Troska, Kim Henderson, Marta Chesi, Morie Gertz, S. Vincent Rajkumar, Robert Kyle, Martha Lacy, Angela Dispenzieri, Philip Greipp, Peter Leif Bergsagel, Rafael Fonseca
Journal: Blood (2005)
THU0052 Association between Antiphospholipid Antibodies and Arterial Thrombotic Events in Patients with Rheumatoid Arthritis
Authors: K.-J. Kim, I.-W. Baek, Y.-J. Park, K.-S. Park, C.-S. Cho
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Antiphospholipid antibodies (aPL) were reported to be found by variable range from 5 to 75% in patients with rheumatoid arthritis (RA) but their clinical significance remains undetermined. <h3>Objectives</h3> The aim of this study is to investigate the association of the presence of aPL with thrombotic events in patients with RA. <h3>Methods</h3> aPL profile, including lupus anticoagulant (LAC), anti-cardiolipin antibodies (aCL), and anti-β<sub>2</sub> glycoprotein I antibodies (aβ<sub>2</sub>GPI), was evaluated in 360 patients with RA according to the standard guideline. Clinical and radiographic data were collected retrospectively. <h3>Results</h3> aPL were identified in 36 patients (10.0%). LAC was the most common type (n=23, 6.4%) and aCL and aβ<sub>2</sub>GPI were detected in 5 and 12 patients (1.4 and 3.4%), respectively. Compared to aPL-negative group, aPL-positive group included more male patients (16 (44.4%) vs. 51 (15.7%), <i>P</i>&lt;0.001) and had higher rate of ever-smoker (14 (38.9%) vs. 51 (15.7%), <i>P</i>=0.005) while there was no difference between two groups in the age, disease duration, and body mass index as well as in the rate of diabetes, hypertension, and dyslipidemia. There was also no significant difference in the positive rate of rheumatoid factor and anti-cyclic citrullinated peptide antibody, values of inflammatory indices and radiographic scores of hand x-ray between two groups. Of note, arterial thrombotic events more commonly developed in aPL-positive group than aPL-negative (5 (13.9%) vs. 7 (2.2%), <i>P</i>=0.004) while venous thrombosis did not differ between two groups (0 (0.0%) vs. 3 (0.9%), <i>P</i>=1.000). In multivariate regression analysis, the presence of aPL, old age, hypertension, and high value of baseline C-reactive protein were independently associated with arterial thrombotic events (<i>P</i>&lt;0.05). <h3>Conclusions</h3> A proportion of RA patients was aPL-positive, and the presence of aPL was independently associated with arterial thrombosis. This result suggests that aPL might be contributable to increased risk for arterial thrombosis in patients with RA. <h3>References</h3> Olech E, Merrill JT. The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Curr Rheumatol Rep 2006;8:100–8. Gladd DA, Olech E. Antiphospholipid antibodies in rheumatoid arthritis: identifying the dominoes. Curr Rheumatol Rep 2009;11:43–51. <h3>Disclosure of Interest</h3> None declared
Reduced Intensity Conditioning Regimen Prior to Unrelated Cord Blood Transplantation In Patients with Acute Myeloid leukemia : Preliminary Analysis of a Prospective Phase II Multicentric Trial on Behalf of Societe Française De Greffe De Moelle Osseuse Et Therapie Cellulaire (SFGM-TC) and Eurocord
Authors: Bernard Rio, Sylvie Chevret, Stephane Vigouroux, Patrice Chevallier, Sabine Furst, Anne Sirvent, Jacques-Olivier Bay, Gerard Socie, Patrice Ceballos, Anne Huynh, Jérôme Cornillon, Sylvie Francois, Faezeh Legrand, Ibrahim Yakoub-Agha, Gerard Michel, Natacha Maillard, Genevieve Margueritte, Sebastien Maury, Madalina Uzunov, Claude Eric Bulabois, Mauricette Michallet, Laurence Clement, Charles Dauriac, Karin Bilger, Tabassome Simon, Eliane Gluckman, Noel Milpied, Vanderson Rocha
Journal: Blood (2010)